Schiffman MH - Search Results

1

Clinical metabolic studies in cancer research.

Taylor PR, Schatzkin A, Patterson BH, Schiffman MH, Albanes D. Taylor PR, et al. Among authors: schiffman mh. Prev Med. 1989 Mar;18(2):194-202. doi: 10.1016/0091-7435(89)90066-2. Prev Med. 1989. PMID: 2662176 Review.

2

Statistical validation of intermediate markers of precancer for use as endpoints in chemoprevention trials.

Freedman LS, Schatzkin A, Schiffman MH. Freedman LS, et al. Among authors: schiffman mh. J Cell Biochem Suppl. 1992;16G:27-32. doi: 10.1002/jcb.240501105. J Cell Biochem Suppl. 1992. PMID: 1469902 Review.

3

Research priorities in large bowel cancer prevention.

Schatzkin A, Schiffman M, Lanza E. Schatzkin A, et al. Semin Oncol. 1990 Aug;17(4):425-37. Semin Oncol. 1990. PMID: 2201088 Review. No abstract available.

4

Validation of intermediate end points in cancer research.

Schatzkin A, Freedman LS, Schiffman MH, Dawsey SM. Schatzkin A, et al. Among authors: schiffman mh. J Natl Cancer Inst. 1990 Nov 21;82(22):1746-52. doi: 10.1093/jnci/82.22.1746. J Natl Cancer Inst. 1990. PMID: 2231769

5

Physical activity and risk of large bowel cancer in the Framingham Study.

Ballard-Barbash R, Schatzkin A, Albanes D, Schiffman MH, Kreger BE, Kannel WB, Anderson KM, Helsel WE. Ballard-Barbash R, et al. Among authors: schiffman mh. Cancer Res. 1990 Jun 15;50(12):3610-3. Cancer Res. 1990. PMID: 2340509

6

Influence of dietary fat on fecal mutagenicity in premenopausal women.

Nair PP, Shami S, Sainz E, Menon M, Jerabek LB, Jones DY, Judd JT, Campbell WS, Schiffman MH, Taylor PR, et al. Nair PP, et al. Among authors: schiffman mh. Int J Cancer. 1990 Sep 15;46(3):374-7. doi: 10.1002/ijc.2910460306. Int J Cancer. 1990. PMID: 2394504 Clinical Trial.

7

Relation of changes in amount and type of dietary fat to fecapentaenes in premenopausal women.

Taylor PR, Schiffman MH, Jones DY, Judd J, Schatzkin A, Nair PP, Van Tassell R, Block G. Taylor PR, et al. Among authors: schiffman mh. Mutat Res. 1988 Sep;206(1):3-9. doi: 10.1016/0165-1218(88)90134-6. Mutat Res. 1988. PMID: 3412371

8

Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia.

Schiffman MH, Schatzkin A. Schiffman MH, et al. Cancer Res. 1994 Apr 1;54(7 Suppl):1944s-1947s. Cancer Res. 1994. PMID: 7794294

9

An epidemiologic perspective on biomarkers.

Schatzkin A, Freedman L, Schiffman M. Schatzkin A, et al. J Intern Med. 1993 Jan;233(1):75-9. doi: 10.1111/j.1365-2796.1993.tb00652.x. J Intern Med. 1993. PMID: 8429292

10

Surrogate end points in cancer research: a critique.

Schatzkin A, Freedman LS, Dorgan J, McShane LM, Schiffman MH, Dawsey SM. Schatzkin A, et al. Among authors: schiffman mh. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):947-53. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8959315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page